3651 results for «394»
3651 results
TMVR today: devices, challenges, and clinical learnings
12 Sep 2025 – From PCR Rio Valves 2025
Explore the evolving landscape of transcatheter mitral valve replacement (TMVR) with a focus on innovative devices, procedural challenges, and clinical learnings. Through a series of case reports, including novel atrial fixation prostheses, devices addressing left ventricular outflow tract obstruction, and complex MitraClip interventions, this session highlights...
Seal the deal: echocardioraphy-guided LAA closure for stroke defense
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on echocardiography-guided left atrial appendage (LAA) closure as a critical strategy for stroke prevention. Attendees will explore optimal cardiac imaging techniques tailored to evolving clinical needs and seasonal considerations. The session also includes comprehensive instruction on post-procedural echocardiographic assessment and post-processing workflows in...
Early outcomes and predictors of success in LATAM TAVI experiences
12 Sep 2025 – From PCR Rio Valves 2025
Explore early outcomes and predictors of success from Latin America's evolving experience with Transcatheter Aortic Valve Implantation (TAVI). This session covers innovative approaches such as transfemoral access intravascular lithotripsy compared to angioplasty, conduction disturbances with self-expandable TAVI devices, and insights from regional centers treating severe aortic...
Mitral valve - The role of the echocardiography imager pre and post intervention
11 Sep 2025 – From PCR Rio Valves 2025
This session emphasizes the critical role of echocardiography imaging pre- and post-mitral valve interventions. It includes case-based post-processing with comprehensive transthoracic and transesophageal echocardiography essential for decision-making in mitral TEER, identification and grading of recurrent mitral regurgitation, and evaluations related to mitral annular calcification and valve-in-calcification...
Addressing challenges in the right heart
11 Sep 2025 – From PCR Rio Valves 2025
This session addresses complex challenges associated with right heart conditions, featuring cases such as post-infarction interventricular septal defect with right heart failure, innovative orthotopic options for tricuspid regurgitation, and advanced edge-to-edge repair using the TRICLIP device. Gain insight into therapeutic strategies for managing severe tricuspid insufficiency...
Management of aortic stenosis: what really matters before and after the procedure
11 Sep 2025 – From PCR Rio Valves 2025
Aortic stenosis management is a lifetime strategy, not a one-time procedure. This session covers key decision-making factors, compares surgical and transcatheter options, and provides guidance on post-procedural care. Learn to individualise treatment based on age, anatomy, and risk, and plan interventions with the patient’s long-term trajectory...
Tricuspid transcatheter therapies: the game changer
29 Sep 2025 – From PCR Gulf Valves 2025
Explore the evolving landscape of tricuspid transcatheter therapies in this comprehensive session reviewing tricuspid regurgitation etiology, anatomy, and current treatment options. Learn about various transcatheter tricuspid valve intervention devices, their strengths and limitations, and the critical diagnostic and intraprocedural imaging requirements to optimize patient selection and...
Mitral valve-in-valves: echocardiography and CT scan
29 Sep 2025 – From PCR Gulf Valves 2025
This session provides in-depth knowledge on imaging planning for mitral valve-in-valve procedures, focusing on echocardiography and CT scan assessment. Learn the critical role of intraprocedural imaging guidance to ensure procedural success and patient safety during mitral valve-in-valve interventions.
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
